CClinicalTrials.gg
CompletedNCT05235282Updated Jun 27, 2024

Effect of Oral Neuromuscular Training on Swallowing

An interventional study of IQoro and Usual care for swallowing function in Dysphagia, sponsored by University of Aarhus. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-27.

Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this randomized controlled trial the investigators wish to investigate the effect of an oral neuromuscular training device (called IQoro) on swallowing function and time until decannulation from a tracheostomy tube, in patients admitted for neurorehabilitation due to a severe acquired brain injury.

02

Conditions studied

  • Dysphagia

Browse trials for

Keywords

  • Dysphagia
03

In context

Deglutition Disorders

710 studies on the registry are indexed under Deglutition Disorders; 219 are open to participants now.

This study's enrollment of 22 is below the median of 60 across 471 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Cuff tracheostomy tube

Exclusion criteria

Exclusion Criteria:

  • Not able to comply with IQoro exercises
  • 3 weeks evaluation stay at the hospital
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Usual care + IQoro

    The intervention group receives usual training of swallowing function along with training 3 times each day with an IQoro oral screen

    Device: IQoro · Other: Usual care for swallowing function

  • Active comparator
    Usual care

    The comparison group receives usual training of swallowing function

    Other: Usual care for swallowing function

Interventions

  • DeviceIQoro

    An acrylic mouth guard with a pulling loop. The mouth guard is placed in the mouth of the patient on the outside of the teeth. The therapist pulls the loop in different directions and the patient try to close his/her mouth on the mouth guard to keep it inside the mouth.

  • OtherUsual care for swallowing function

    Cuff deflation, speaking valve, masako exercises, shaker exercises, coughing, stimulation of the oral cavity, neuromuscular electrical stimulation, postural control

06

What researchers measure

Primary outcomes

  1. Number of days from admission until decannulation

    Time from admission until decannulation from a tracheostomy tube. For patients still admitted, decannulation is determined from the clinicians and documented i medical records. For discharged patients, decannulation is determined through medical records.

    Time frame: Number of days from baseline assessment until decannulation or right censoring at 365 days

Secondary outcomes

  1. Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS)

    FEDSS is a scale used for Fiberoptic Endoscopic Evaluation of Swallowing. FEDSS range is 1-6, with lower scores representing better outcome

    Time frame: Baseline and after four weeks

  2. Penetration Aspiration Scale (PAS)

    PAS is a scale used for Fiberoptic Endoscopic Evaluation of Swallowing. PAS range is 1-8, with lower scores representing better outcome

    Time frame: Baseline and after four weeks

  3. Yale Pharyngeal Residue Scale

    Yale Pharyngeal Residue Scale is a scale used for Fiberoptic Endoscopic Evaluation of Swallowing. The Yale Scale encompass two subscales with score 1-5 on each scale, with 1 representing better outcome.

    Time frame: Baseline and after four weeks

  4. Milliliters of saliva above the cuff

    Daily amount of saliva above the cuff of the tracheostomy tube

    Time frame: Daily measures for up to four weeks

  5. Functional oral intake (FOIS)

    FOIS range is 1-7, with 7 representing better outcome

    Time frame: Baseline and after four weeks

  6. Iowa Oral Performance Instrument (IOPI)

    Lip strength measured with the IOPI. Measured in Pascal with greater values representing greater strength

    Time frame: Baseline and after four weeks

07

Study locations

1 site
  • Hammel Neurorehabilitation Centre and University Research Clinic
    Hammel, Midtjylland 8450, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05235282
Lead sponsor
University of Aarhus
Collaborators
Hammel Neurorehabilitation Centre and University Research Clinic
Responsible party
Sponsor
First posted
Feb 11, 2022
Start date
May 6, 2022
Primary completion
May 10, 2024
Completion
May 10, 2024
Last update
Jun 27, 2024

Study contacts

Jesper Fabricius, PhD
principal investigator · Hammel Neurorehabilitation Centre and University Research Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion